Nonsteroidal Mineralocorticoid Receptor Antagonist in Type 2 Diabetes–Associated Chronic Kidney Disease

A leading expert provides an overview of the cardiorenal benefits of finerenone in patients with type 2 diabetes and chronic kidney disease.
Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP
Format: Microsoft PowerPoint (.ppt)
File Size: 2.54 MB
Released: July 7, 2022

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

This activity is supported by independent educational grants from
Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company
Bayer HealthCare Pharmaceuticals Inc.

Related Content

Downloadable slides on osteoporosis pharmacotherapy in adults, provided by Clinical Care Options (CCO)

person default E. Michael Lewiecki, MD Released: November 17, 2022

Downloadable slides on therapeutic interventions for NAFLD/NASH, from Clinical Care Options (CCO)

Manal F. Abdelmalek, MD, MPH Rohit Loomba, MD, MHSc Brent A. Neuschwander-Tetri, MD Released: November 4, 2022

Expert commentary on the importance of collaboration when working with patients to manage weight, from Clinical Care Options (CCO)

Jennifer Clements, PharmD, FCCP, FADCES, BCPS, CDCES, BCACP, BC-ADM Released: November 2, 2022

Unlocked downloadable slides featuring experts insight on the management of patients with obesity from Clinical Care Options (CCO).

Caroline Apovian, MD Ken Fujioka, MD Released: November 2, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings